Home
TNXP
TNXP News

Latest Tonix Pharmaceuticals Holding Corp. (TNXP) News on August 17, 2025

MT Newswires

2 months ago

Tonix Pharmaceuticals to Join Russell Indexes

Tonix Pharmaceuticals Announces Inclusion in the Russell 3000® and Russell 2000® Indexes

GlobeNewswire

2 months ago

Tonix Pharmaceuticals Announces Inclusion in the Russell 3000® and Russell 2000® Indexes

Tonix Pharmaceuticals Presented Data and Analyses of TNX-102 SL Treatment Effects on Fibromyalgia at the Annual European Congress of Rheumatology (EULAR) 2025

GlobeNewswire

2 months ago

Tonix Pharmaceuticals Presented Data and Analyses of TNX-102 SL Treatment Effects on Fibromyalgia at the Annual European Congress of Rheumatology (EULAR) 2025

Tonix Pharmaceuticals Announces Appointment of Commercial Industry Veteran, James “Jim” Hunter, to Board of Directors

GlobeNewswire

2 months ago

Tonix Pharmaceuticals Announces Appointment of Commercial Industry Veteran, James “Jim” Hunter, to Board of Directors

MT Newswires

2 months ago

Top Premarket Decliners

MT Newswires

2 months ago

Tonix Pharmaceuticals Plans Potential Share Sale of Up to $150 Million; Stock Falls Premarket

Tonix Pharmaceuticals Announces Presentation at the 2025 BIO International Convention

GlobeNewswire

2 months ago

Tonix Pharmaceuticals Announces Presentation at the 2025 BIO International Convention

Tonix Pharmaceuticals Announces Poster Presentation at the Annual European Congress of Rheumatology (EULAR) 2025

GlobeNewswire

2 months ago

Tonix Pharmaceuticals Announces Poster Presentation at the Annual European Congress of Rheumatology (EULAR) 2025

TNXP: Preparations Continue for Potential Commercial Launch of TNX-102 SL in Fibromyalgia…

Zacks Small Cap Research

3 months ago

TNXP: Preparations Continue for Potential Commercial Launch of TNX-102 SL in Fibromyalgia…

Tonix Pharmaceuticals Announces Presentation at the A.G.P. Annual Healthcare Company Showcase

GlobeNewswire

3 months ago

Tonix Pharmaceuticals Announces Presentation at the A.G.P. Annual Healthcare Company Showcase

Tonix Pharmaceuticals Announces First Patient Dosed in Phase 2 OASIS Study of TNX-102 SL for Reduction of Acute Stress Reaction

GlobeNewswire

3 months ago

Tonix Pharmaceuticals Announces First Patient Dosed in Phase 2 OASIS Study of TNX-102 SL for Reduction of Acute Stress Reaction

Tonix Pharmaceuticals Announces Appointment of Joseph Hand, Esq., as General Counsel and Executive Vice President of Operations

GlobeNewswire

3 months ago

Tonix Pharmaceuticals Announces Appointment of Joseph Hand, Esq., as General Counsel and Executive Vice President of Operations

Tonix Pharmaceuticals Reports First Quarter 2025 Financial Results and Operational Highlights

GlobeNewswire

3 months ago

Tonix Pharmaceuticals Reports First Quarter 2025 Financial Results and Operational Highlights

Tonix Pharmaceuticals Presented Preclinical Data on Gastric Cancer Models at the American Association for Cancer Research (AACR) 2025 Annual Meeting

GlobeNewswire

4 months ago

Tonix Pharmaceuticals Presented Preclinical Data on Gastric Cancer Models at the American Association for Cancer Research (AACR) 2025 Annual Meeting

Tonix Pharmaceuticals Presented Data on Potential Mpox Vaccine TNX-801 at World Vaccine Congress Washington 2025

GlobeNewswire

4 months ago

Tonix Pharmaceuticals Presented Data on Potential Mpox Vaccine TNX-801 at World Vaccine Congress Washington 2025

Tonix Pharmaceuticals Announces Oral Presentation and Panel Participation at the World Vaccine Congress Washington 2025

GlobeNewswire

4 months ago

Tonix Pharmaceuticals Announces Oral Presentation and Panel Participation at the World Vaccine Congress Washington 2025

Why Tonix Pharmaceuticals Corp. (TNXP) Went Down On Thursday?

Insider Monkey

4 months ago

Why Tonix Pharmaceuticals Corp. (TNXP) Went Down On Thursday?

Tonix Pharmaceuticals and Makana Therapeutics Announce Collaboration Combining Tonix’s Anti-CD40L Monoclonal Antibody (TNX-1500) with Makana’s Genetically Engineered Organs in Preclinical and Clinical Xenotransplantation Studies

GlobeNewswire

4 months ago

Tonix Pharmaceuticals and Makana Therapeutics Announce Collaboration Combining Tonix’s Anti-CD40L Monoclonal Antibody (TNX-1500) with Makana’s Genetically Engineered Organs in Preclinical and Clinical Xenotransplantation Studies

Tonix Pharmaceuticals Presented Data and Analyses of TNX-102 SL Treatment Effects on Fibromyalgia at the American Academy of Pain Medicine (AAPM) 2025 Annual Meeting

GlobeNewswire

4 months ago

Tonix Pharmaceuticals Presented Data and Analyses of TNX-102 SL Treatment Effects on Fibromyalgia at the American Academy of Pain Medicine (AAPM) 2025 Annual Meeting

TNXP: No AdCom Required for TNX-102 SL NDA…

Zacks Small Cap Research

4 months ago

TNXP: No AdCom Required for TNX-102 SL NDA…

Tonix Pharmaceuticals to Present at the 2025 Jones Trading Healthcare and Innovation Conference

GlobeNewswire

4 months ago

Tonix Pharmaceuticals to Present at the 2025 Jones Trading Healthcare and Innovation Conference

Tonix Pharmaceuticals Launches TONIX ONE™, a Fully-Integrated Digital Platform Designed to Help Patients Better Understand and Manage Their Migraine Condition

GlobeNewswire

5 months ago

Tonix Pharmaceuticals Launches TONIX ONE™, a Fully-Integrated Digital Platform Designed to Help Patients Better Understand and Manage Their Migraine Condition

Tonix’s Experimental Non-Opioid Analgesic Treatment for Fibromyalgia Could Start Bringing Relief Later This Year

ACCESS Newswire

5 months ago

Tonix’s Experimental Non-Opioid Analgesic Treatment for Fibromyalgia Could Start Bringing Relief Later This Year

ACCESS Newswire

5 months ago

New to The Street Show #639 Premieres Nationwide on Bloomberg Television, March 29 at 6:30 PM EST Featuring BioVie, Roadzen, Tonix Pharma, and eXoZymes Inc.

Tonix Pharmaceuticals Announces Presentation at the American Academy of Pain Medicine (AAPM) 2025 Annual Meeting

GlobeNewswire

5 months ago

Tonix Pharmaceuticals Announces Presentation at the American Academy of Pain Medicine (AAPM) 2025 Annual Meeting

MT Newswires

5 months ago

Sector Update: Health Care Stocks Higher in Afternoon Trading

MT Newswires

5 months ago

Sector Update: Health Care

MT Newswires

5 months ago

Update: Tonix Pharmaceuticals Says US FDA Will Not Require Committee Meeting to Discuss NDA for Fibromyalgia Treatment; Shares Up

MT Newswires

5 months ago

Sector Update: Health Care Stocks Edge Higher Premarket Monday

MT Newswires

5 months ago

Tonix Pharmaceuticals Says US FDA Will Not Require Committee Meeting to Discuss NDA for Fibromyalgia Treatment

Tonix Pharmaceuticals Announces that FDA Will Not Require an Advisory Committee Meeting to Discuss New Drug Application for TNX-102 SL for the Management of Fibromyalgia

GlobeNewswire

5 months ago

Tonix Pharmaceuticals Announces that FDA Will Not Require an Advisory Committee Meeting to Discuss New Drug Application for TNX-102 SL for the Management of Fibromyalgia

As Mpox Cases Spread Around the World, Tonix Pharmaceuticals’ Single-Dose Vaccine TNX-801 Has Potential to Slow the Spread

ACCESS Newswire

5 months ago

As Mpox Cases Spread Around the World, Tonix Pharmaceuticals’ Single-Dose Vaccine TNX-801 Has Potential to Slow the Spread

Tonix Pharmaceuticals Reports Fourth Quarter and Full Year 2024 Financial Results and Operational Highlights

GlobeNewswire

5 months ago

Tonix Pharmaceuticals Reports Fourth Quarter and Full Year 2024 Financial Results and Operational Highlights

Life Science Virtual Investor Forum: Presentations Now Available for Online Viewing

GlobeNewswire

5 months ago

Life Science Virtual Investor Forum: Presentations Now Available for Online Viewing

Tonix Pharmaceuticals Announces Presentation at BIO-Europe Spring 2025

GlobeNewswire

5 months ago

Tonix Pharmaceuticals Announces Presentation at BIO-Europe Spring 2025

Life Sciences Investor Forum Agenda Announced for March 13th

GlobeNewswire

5 months ago

Life Sciences Investor Forum Agenda Announced for March 13th

Tonix’s TNX-1500 Shows Promise in Preventing Organ Transplant Rejections of Either Human or Pig Organs; Autoimmune Diseases Also a Target

ACCESS Newswire

5 months ago

Tonix’s TNX-1500 Shows Promise in Preventing Organ Transplant Rejections of Either Human or Pig Organs; Autoimmune Diseases Also a Target

Tonix Pharmaceuticals to Present at the Zacks SCR Life Sciences Virtual Investor Forum on March 13th

GlobeNewswire

5 months ago

Tonix Pharmaceuticals to Present at the Zacks SCR Life Sciences Virtual Investor Forum on March 13th

Tonix Pharmaceuticals Announces Grant by Medical CBRN Defense Consortium (MCDC) for Development of TNX-801, the Company’s Single-Dose Mpox and Smallpox Vaccine Candidate

GlobeNewswire

5 months ago

Tonix Pharmaceuticals Announces Grant by Medical CBRN Defense Consortium (MCDC) for Development of TNX-801, the Company’s Single-Dose Mpox and Smallpox Vaccine Candidate

Why Tonix Pharmaceuticals Holding Corp. (TNXP) Soared Last Week

Insider Monkey

5 months ago

Why Tonix Pharmaceuticals Holding Corp. (TNXP) Soared Last Week

Why Tonix Pharmaceuticals Holding Corp. (TNXP) Soared on Thursday

Insider Monkey

5 months ago

Why Tonix Pharmaceuticals Holding Corp. (TNXP) Soared on Thursday

A 41% Surge? This Small-Cap Pharma Stock Just Shook Up the Fibromyalgia Market

GuruFocus.com

5 months ago

A 41% Surge? This Small-Cap Pharma Stock Just Shook Up the Fibromyalgia Market

Tonix Surges 31% Following Positive Phase 3 Fibromyalgia Drug Trial Results

GuruFocus.com

5 months ago

Tonix Surges 31% Following Positive Phase 3 Fibromyalgia Drug Trial Results

Tonix Pharmaceuticals to Present at the 2025 Virtual Investor Summit

GlobeNewswire

5 months ago

Tonix Pharmaceuticals to Present at the 2025 Virtual Investor Summit

Tonix Pharmaceuticals Presented Data and Analyses of TNX-102 SL Treatment Effects on Fibromyalgia at 7th International Congress on Controversies in Fibromyalgia

GlobeNewswire

5 months ago

Tonix Pharmaceuticals Presented Data and Analyses of TNX-102 SL Treatment Effects on Fibromyalgia at 7th International Congress on Controversies in Fibromyalgia

TNXP: PDUFA Date for TNX-102 SL in Fibromyalgia of August 15, 2025…

Zacks Small Cap Research

6 months ago

TNXP: PDUFA Date for TNX-102 SL in Fibromyalgia of August 15, 2025…

MT Newswires

6 months ago

Tonix Pharmaceuticals Rises After Preliminary 2024 Results

Tonix Pharmaceuticals reports positive topline trial outcomes of TNX-1500

Clinical Trials Arena

6 months ago

Tonix Pharmaceuticals reports positive topline trial outcomes of TNX-1500

Tonix Pharmaceuticals Recently Announced Preliminary Full Year 2024 Operating Results and Year-End Cash

GlobeNewswire

6 months ago

Tonix Pharmaceuticals Recently Announced Preliminary Full Year 2024 Operating Results and Year-End Cash

Tonix Pharmaceuticals Announces Positive Topline Results from Phase 1 Trial for TNX-1500, a Next Generation anti-CD40L mAb Candidate for Prevention of Kidney Transplant Rejection and Treatment of Autoimmune Diseases

GlobeNewswire

6 months ago

Tonix Pharmaceuticals Announces Positive Topline Results from Phase 1 Trial for TNX-1500, a Next Generation anti-CD40L mAb Candidate for Prevention of Kidney Transplant Rejection and Treatment of Autoimmune Diseases

Tonix Pharmaceuticals to Participate in the 2025 BIO CEO & Investor Conference

GlobeNewswire

6 months ago

Tonix Pharmaceuticals to Participate in the 2025 BIO CEO & Investor Conference

Tonix Pharmaceuticals Promotes Siobhan Fogarty to Chief Technical Officer

GlobeNewswire

6 months ago

Tonix Pharmaceuticals Promotes Siobhan Fogarty to Chief Technical Officer

Tonix Pharmaceuticals Announces 1-for-100 Reverse Stock Split

GlobeNewswire

6 months ago

Tonix Pharmaceuticals Announces 1-for-100 Reverse Stock Split

Tonix Pharmaceuticals Further Strengthens Commercial Leadership Team with Appointment of Gary Ainsworth as Vice President of Market Access

GlobeNewswire

7 months ago

Tonix Pharmaceuticals Further Strengthens Commercial Leadership Team with Appointment of Gary Ainsworth as Vice President of Market Access

Tonix Pharmaceuticals to Present at Two Upcoming January Investor Conferences

GlobeNewswire

7 months ago

Tonix Pharmaceuticals to Present at Two Upcoming January Investor Conferences

MT Newswires

8 months ago

Tonix Pharmaceuticals Says FDA Set Target Action Date for Potential Fibromyalgia Drug

Tonix Pharmaceuticals Announces PDUFA Goal Date of August 15, 2025, for FDA Decision on U.S. Marketing Approval for TNX-102 SL for Fibromyalgia

GlobeNewswire

8 months ago

Tonix Pharmaceuticals Announces PDUFA Goal Date of August 15, 2025, for FDA Decision on U.S. Marketing Approval for TNX-102 SL for Fibromyalgia

MT Newswires

8 months ago

Tonix Pharmaceuticals Shares Jump After FDA Accepts NDA for Fibromyalgia Drug

Tonix Pharmaceuticals Announces FDA Acceptance of the New Drug Application (NDA) for TNX-102 SL for Fibromyalgia

GlobeNewswire

8 months ago

Tonix Pharmaceuticals Announces FDA Acceptance of the New Drug Application (NDA) for TNX-102 SL for Fibromyalgia

Tonix Pharmaceuticals Reports Third Quarter 2024 Financial Results and Operational Highlights

GlobeNewswire

8 months ago

Tonix Pharmaceuticals Reports Third Quarter 2024 Financial Results and Operational Highlights

Tonix's TNX 102-SL Could Offer New Hope of Pain Relief Without Narcotics for Fibromyalgia Sufferers

ACCESSWIRE

8 months ago

Tonix's TNX 102-SL Could Offer New Hope of Pain Relief Without Narcotics for Fibromyalgia Sufferers

Tonix Pharmaceuticals Announces Expansion of Leadership Team with Two Strategic Hires

GlobeNewswire

8 months ago

Tonix Pharmaceuticals Announces Expansion of Leadership Team with Two Strategic Hires

TNXP: NDA Filed for TNX-102 SL in Fibromyalgia…

Zacks Small Cap Research

8 months ago

TNXP: NDA Filed for TNX-102 SL in Fibromyalgia…

Tonix Pharmaceuticals to Participate in the NobleCon20 Investor Conference

GlobeNewswire

9 months ago

Tonix Pharmaceuticals to Participate in the NobleCon20 Investor Conference

Tonix Pharmaceuticals to Present at the Winter 2024 Investor Summit Virtual

GlobeNewswire

9 months ago

Tonix Pharmaceuticals to Present at the Winter 2024 Investor Summit Virtual

Tonix Pharmaceuticals Presented Data and Analyses of TNX-102 SL Treatment Effects on Fibromyalgia at the American College of Rheumatology (ACR) Convergence 2024 Annual Meeting

GlobeNewswire

9 months ago

Tonix Pharmaceuticals Presented Data and Analyses of TNX-102 SL Treatment Effects on Fibromyalgia at the American College of Rheumatology (ACR) Convergence 2024 Annual Meeting

Tonix Pharmaceuticals Targets Rapid Migraine Relief With Non-Oral Treatments

ACCESSWIRE

9 months ago

Tonix Pharmaceuticals Targets Rapid Migraine Relief With Non-Oral Treatments

Tonix Pharmaceuticals Announces Poster Presentation at the American College of Rheumatology (ACR) Convergence 2024 Annual Meeting

GlobeNewswire

9 months ago

Tonix Pharmaceuticals Announces Poster Presentation at the American College of Rheumatology (ACR) Convergence 2024 Annual Meeting

Tonix Pharmaceuticals Announces Peer-Reviewed Publication in mSphere Journal Highlighting the Tolerability of Company’s Single-Dose Mpox and Smallpox Vaccine Candidate TNX-801, in Immune-Compromised Animals

GlobeNewswire

9 months ago

Tonix Pharmaceuticals Announces Peer-Reviewed Publication in mSphere Journal Highlighting the Tolerability of Company’s Single-Dose Mpox and Smallpox Vaccine Candidate TNX-801, in Immune-Compromised Animals

Tonix Pharma Partners for Vaccine Clinical Trial

TipRanks

9 months ago

Tonix Pharma Partners for Vaccine Clinical Trial

Tonix Pharmaceuticals Announces Research Agreement with Kenya Medical Research Institute (KEMRI) to Design, Plan and Seek Regulatory Approval for a Phase I Clinical Study of TNX-801 for Mpox in Kenya

GlobeNewswire

9 months ago

Tonix Pharmaceuticals Announces Research Agreement with Kenya Medical Research Institute (KEMRI) to Design, Plan and Seek Regulatory Approval for a Phase I Clinical Study of TNX-801 for Mpox in Kenya

Tonix Pharmaceuticals Presented Data on Potential Mpox Vaccine TNX-801 at World Vaccine Congress-Europe 2024

GlobeNewswire

10 months ago

Tonix Pharmaceuticals Presented Data on Potential Mpox Vaccine TNX-801 at World Vaccine Congress-Europe 2024

Tonix Pharmaceuticals to Present at BIO-Europe® 2024

GlobeNewswire

10 months ago

Tonix Pharmaceuticals to Present at BIO-Europe® 2024

Tonix Pharmaceuticals to Present at the 2024 ThinkEquity Conference

GlobeNewswire

10 months ago

Tonix Pharmaceuticals to Present at the 2024 ThinkEquity Conference

Tonix Pharmaceuticals Announces Oral Presentation at the World Vaccine Congress Europe 2024

GlobeNewswire

10 months ago

Tonix Pharmaceuticals Announces Oral Presentation at the World Vaccine Congress Europe 2024

MT Newswires

10 months ago

Tonix Pharmaceuticals Shares Surge After 1st Payment From Defense Department

Tonix Pharmaceuticals Receives First Contract Payment from U.S. Department of Defense for Accelerated Development of Broad-Spectrum Antivirals with the Defense Threat Reduction Agency (DTRA)

GlobeNewswire

10 months ago

Tonix Pharmaceuticals Receives First Contract Payment from U.S. Department of Defense for Accelerated Development of Broad-Spectrum Antivirals with the Defense Threat Reduction Agency (DTRA)

Empery Asset Management LP Acquires Shares in Tonix Pharmaceuticals

GuruFocus.com

10 months ago

Empery Asset Management LP Acquires Shares in Tonix Pharmaceuticals

MT Newswires

10 months ago

Tonix Pharmaceuticals Files New Drug Application With FDA for TNX-102 SL to Treat Fibromyalgia

Tonix Pharmaceuticals Announces Submission of the TNX-102 SL New Drug Application (NDA) for Fibromyalgia to the U.S. Food and Drug Administration (FDA)

GlobeNewswire

10 months ago

Tonix Pharmaceuticals Announces Submission of the TNX-102 SL New Drug Application (NDA) for Fibromyalgia to the U.S. Food and Drug Administration (FDA)

Tonix Pharma Enhances Drug Development with AI Partnership

TipRanks

10 months ago

Tonix Pharma Enhances Drug Development with AI Partnership

Tonix Pharmaceuticals Announces AI Collaboration with X-Chem to Develop Broad-Spectrum Antivirals

GlobeNewswire

10 months ago

Tonix Pharmaceuticals Announces AI Collaboration with X-Chem to Develop Broad-Spectrum Antivirals

The Rush for Non-Addictive Painkillers to Counter the Opioid Crisis Puts Two Companies Close to FDA Decisions

ACCESSWIRE

a year ago

The Rush for Non-Addictive Painkillers to Counter the Opioid Crisis Puts Two Companies Close to FDA Decisions

Tonix Pharmaceuticals Announces Participation in Endpoints Panel at the Long COVID Workshop and RECOVER TLC Workshop Convened by the Foundation for the National Institutes of Health (FNIH) and the National Institute of Allergy and Infectious Diseases (NIAID)

GlobeNewswire

a year ago

Tonix Pharmaceuticals Announces Participation in Endpoints Panel at the Long COVID Workshop and RECOVER TLC Workshop Convened by the Foundation for the National Institutes of Health (FNIH) and the National Institute of Allergy and Infectious Diseases (NIAID)

MT Newswires

a year ago

Tonix Pharmaceuticals Receives US Patent for Migraine Treatment; Shares Rise

Tonix Pharmaceuticals Announces Issuance of U.S. Patent Covering the Subcutaneous Delivery of FDA-Approved Zembrace® SymTouch® to Treat Migraines

GlobeNewswire

a year ago

Tonix Pharmaceuticals Announces Issuance of U.S. Patent Covering the Subcutaneous Delivery of FDA-Approved Zembrace® SymTouch® to Treat Migraines

Tonix Pharmaceuticals Announces Data Presentations on TNX-102 SL for Fibromyalgia at the 11th Global Conference on Pharmaceutics and Novel Drug Delivery Systems (PDDS 2024)

GlobeNewswire

a year ago

Tonix Pharmaceuticals Announces Data Presentations on TNX-102 SL for Fibromyalgia at the 11th Global Conference on Pharmaceutics and Novel Drug Delivery Systems (PDDS 2024)

MT Newswires

a year ago

Tonix Pharmaceuticals Secures US Patent for Migraine Treatment -- Shares Rise Pre-Bell

Tonix Pharmaceuticals Announces Issuance of U.S. Patent by the United States Patent and Trademark Office Covering the Intranasal Delivery of FDA-Approved Tosymra® to Treat Migraines

GlobeNewswire

a year ago

Tonix Pharmaceuticals Announces Issuance of U.S. Patent by the United States Patent and Trademark Office Covering the Intranasal Delivery of FDA-Approved Tosymra® to Treat Migraines

New Hope for Mpox? How TNX-801 Could Meet the WHO's Vaccine Targets for a Safer, Single-Dose Solution

ACCESSWIRE

a year ago

New Hope for Mpox? How TNX-801 Could Meet the WHO's Vaccine Targets for a Safer, Single-Dose Solution

GlobeNewswire

a year ago

Tonix Pharmaceuticals Announces That its Single Dose Mpox Vaccine Candidate TNX-801 Aligns with WHO’s Newly Issued Preferred Target Product Profile for Mpox Vaccines in Global Health Emergency

Investor Summit August 2024 Presentations Now Accessible for On-Demand Viewing

ACCESSWIRE

a year ago

Investor Summit August 2024 Presentations Now Accessible for On-Demand Viewing

Tonix Pharmaceuticals Announces Appointment of Thomas Englese as Executive Vice President of Commercial Operations

GlobeNewswire

a year ago

Tonix Pharmaceuticals Announces Appointment of Thomas Englese as Executive Vice President of Commercial Operations

TNXP: Mpox Declared a Public Health Emergency of International Concern by World Health Organization…

Zacks Small Cap Research

a year ago

TNXP: Mpox Declared a Public Health Emergency of International Concern by World Health Organization…

MT Newswires

a year ago

Tonix Pharmaceuticals Says Mpox Vaccine Effective in Animal Tests

Tonix Pharmaceuticals Presented Data on the Potential Mpox Vaccine TNX-801 in “Using Synthetic Biology to Battle Mpox” Talk at Immunology Symposium at the University of Alberta

GlobeNewswire

a year ago

Tonix Pharmaceuticals Presented Data on the Potential Mpox Vaccine TNX-801 in “Using Synthetic Biology to Battle Mpox” Talk at Immunology Symposium at the University of Alberta

Tonix Pharmaceuticals Launches National Awareness Campaign on the Impact of Gastroparesis or Stomach Paralysis on the Absorption of Oral Migraine Medications at PAINWeek

GlobeNewswire

a year ago

Tonix Pharmaceuticals Launches National Awareness Campaign on the Impact of Gastroparesis or Stomach Paralysis on the Absorption of Oral Migraine Medications at PAINWeek

As Research into Pain Accelerates, a Newly Recognized Type of Pain Comes to the Forefront - Tonix Targets it with FDA-Fast Track-Designated TNX-102 SL

ACCESSWIRE

a year ago

As Research into Pain Accelerates, a Newly Recognized Type of Pain Comes to the Forefront - Tonix Targets it with FDA-Fast Track-Designated TNX-102 SL

Tonix Pharmaceuticals Presented Data from Two Posters on TNX-102 SL for Reduction of Acute Stress Reaction and Prevention of PTSD and One Poster for Wound Healing at the 2024 Military Health System Research Symposium (MHSRS)

GlobeNewswire

a year ago

Tonix Pharmaceuticals Presented Data from Two Posters on TNX-102 SL for Reduction of Acute Stress Reaction and Prevention of PTSD and One Poster for Wound Healing at the 2024 Military Health System Research Symposium (MHSRS)

Tonix Pharmaceuticals Presented Data and Analyses of TNX-102 SL Treatment Effects on Fibromyalgia at the 2024 Military Health System Research Symposium (MHSRS)

GlobeNewswire

a year ago

Tonix Pharmaceuticals Presented Data and Analyses of TNX-102 SL Treatment Effects on Fibromyalgia at the 2024 Military Health System Research Symposium (MHSRS)

Share on Social Networks: